SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013262
Filing Date
2022-08-11
Accepted
2022-08-11 16:02:33
Documents
54
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrns-20220630x10q.htm   iXBRL 10-Q 1283835
2 EX-31.1 mrns-20220630xex31d1.htm EX-31.1 13244
3 EX-31.2 mrns-20220630xex31d2.htm EX-31.2 13353
4 EX-32.1 mrns-20220630xex32d1.htm EX-32.1 7672
5 GRAPHIC mrns-20220630x10q007.jpg GRAPHIC 72974
6 GRAPHIC mrns-20220630x10q004.jpg GRAPHIC 14134
  Complete submission text file 0001558370-22-013262.txt   5393194

Data Files

Seq Description Document Type Size
7 EX-101.SCH mrns-20220630.xsd EX-101.SCH 39769
8 EX-101.CAL mrns-20220630_cal.xml EX-101.CAL 46660
9 EX-101.DEF mrns-20220630_def.xml EX-101.DEF 141485
10 EX-101.LAB mrns-20220630_lab.xml EX-101.LAB 350624
11 EX-101.PRE mrns-20220630_pre.xml EX-101.PRE 246561
48 EXTRACTED XBRL INSTANCE DOCUMENT mrns-20220630x10q_htm.xml XML 789150
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 221155570
SIC: 2834 Pharmaceutical Preparations